Tenuifolin in the prevention of Alzheimers disease-like phenotypes: investigation of the mechanisms from the perspectives of calpain system, ferroptosis, and apoptosis
A 2021 review covering 30 years of clinical data described cerebrolysin as demonstrating "a disease-modifying effect by slowing down the progression" of Alzheimer disease, but this language outpaces what the clinical trial designs can definitively prove
Nootropics Depot advertises the product as being effective for "cellular support, metabolic function, and cognition," none of which are typically associated with silymarin
It includes probiotics and terpenes, a plant compound, which together increase the effectiveness of glutathione delivery
Pharmaceutical giants Novo Nordisk and Eli Lilly have driven valuations to new heights, but recent proposals to slash drug prices are adding volatility to the market